CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract
CD1a 阴道树突状细胞和女性生殖道中 HIV-1 的获得
基本信息
- 批准号:8846903
- 负责人:
- 金额:$ 44.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-15 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntigensApicalBirbeck GranuleC Type Lectin ReceptorsCCR5 geneCD4 Positive T LymphocytesCXCR4 ReceptorsCXCR4 geneCell LineageCell Surface ReceptorsCell physiologyCellsCervicalCharacteristicsChargeChemokine (C-C Motif) Receptor 5ChronicCoculture TechniquesDataDendritesDendritic CellsDermisElectron MicroscopyEpithelialEpitheliumEventExclusionFemaleGenerationsGeneticGenital systemGenotypeGoalsHIV-1HeterosexualsIndividualInfectionInfection preventionInterferonsLangerhans cellLengthLymphocyteMethodsModelingMucous MembraneOutcomePhenotypePlayPredispositionProcessProductionPropertyRelative (related person)ResistanceRoleSexual TransmissionSiteSkinSurfaceSystemic infectionT-LymphocyteTissuesV3 LoopVaginaVariantVirionVirusVirus ReplicationWestern BlottingWomanWorkadaptive immunitybasechemokinecytokineimmunological synapseinhibitor/antagonistlangerinmicrobicidemicroorganismmonocytenovelnovel vaccinespreventpublic health relevancereceptorsexual encountertransmission process
项目摘要
DESCRIPTION (provided by applicant): The majority of new HIV-1 infections in the world are acquired by women after heterosexual contact. During sexual transmission, HIV-1 must get across the genital mucosa, infect and replicate in the early target cells, and then disseminate from the initial site of invasion to generate a systemic infection. HIV-1 primarily replicates in CD4+ lymphocytes, but these cells are mostly absent from intact mucosal surfaces. Tissue based dendritic cells (DCs), known as Langerhans cells (LCs), are generally believed to facilitate HIV-1 access to CD4+ T cells. Because it has been difficult to isolate tissue based dendritic cells, most studies employ monocyte derived dendritic cells (MDDCs) or skin derived LC as surrogates. We have developed novel methods to isolate tissue based dendritic cells termed CD1a+ vaginal dendritic cells (VDCs) from discarded vaginal tissue. The previously uncharacterized CD1a+ VDCs possess unique cell surface receptors, intracellular features and susceptibility. Most importantly, we show that HIV-1, able to utilize the CCR5 receptor, (termed R5) is able to replicate in CD1a+ VDCs while variants that use the CXCR4 receptor (termed X4) fail to infect these cells. Because viruses acquired by newly infected subjects predominantly use the CCR5 receptor although transmitting partners often harbor both R5 and CXCR4 utilizing virions, our data explains this most fundamental observation about coreceptor restriction during HIV-1 acquisition. We hypothesize that CD1a+ VDC project dendrites into the vaginal lumen. These dendrites allow CCR5 but not CXCR4 using viruses to be acquired from the vaginal lumen. Local replication in CD1a+ VDCs facilitates virus transfer across the mucosal epithelium to deeper lying CD4+ T cells. Besides increasing HIV-1's ability to infect and replicate in deeper lying CD4+ lymphocytes, we hypothesize that CD1a+ VDCs also determine which HIV-1 variants establish a productive infection within a naive host. During sexual transmission, a newly infected subject acquires only a limited number of R5 variants from the diverse X4 and R5 viruses circulating in the chronically infected transmitting partner. In addition, infecting R5 viruses often have unique genotypes and phenotypes compared to the quasispecies present in the transmitting partner. We hypothesize that CD1a+ VDCs function as gate keepers, both blocking X4 viruses and favoring the replication of R5 variants with properties often found among HIV-1 isolated early after infection. In the proposal, we will examine mechanisms that allow CD1a+ VDC to be susceptible to R5 but resistant to X4 HIV-1. We will examine if these cells allow preferential replication of the infecting strains compared to non-transmitted viruses. We will also explore inhibitors that can prevent replication in CD1a+ VDCs and transfer of virus to CD4+ T cells. Delineating the mechanistic details and factors that can prevent infection in CD1a+ VDCs or virus transfer to CD4+ T cells will suggest novel vaccine and microbicide strategies aimed at preventing HIV-1 mucosal transmission.
描述(由申请人提供):世界上大多数新的HIV-1感染是由女性在异性接触后获得的。在性传播过程中,HIV-1必须穿过生殖器粘膜,在早期靶细胞中感染和复制,然后从最初的侵入部位传播,产生全身感染。HIV-1主要在CD 4+淋巴细胞中复制,但这些细胞大多不存在于完整的粘膜表面。基于组织的树突状细胞(DC),称为朗格汉斯细胞(LC),通常被认为促进HIV-1接近CD 4 + T细胞。由于难以分离基于组织的树突状细胞,大多数研究采用单核细胞衍生的树突状细胞(MDDC)或皮肤衍生的LC作为替代物。我们已经开发了新的方法来分离组织为基础的树突状细胞称为CD 1a+阴道树突状细胞(VDC)从废弃的阴道组织。以前未表征的CD 1a + VDCs具有独特的细胞表面受体、细胞内特征和易感性。最重要的是,我们表明,能够利用CCR 5受体(称为R5)的HIV-1能够在CD 1a + VDC中复制,而使用CXCR 4受体(称为X4)的变体无法感染这些细胞。由于新感染受试者获得的病毒主要使用CCR 5受体,尽管传播伙伴通常同时携带R5和CXCR 4利用病毒体,我们的数据解释了HIV-1获得过程中关于辅助受体限制的最基本观察结果。我们假设CD 1a + VDC向阴道腔投射树突。这些树突允许使用病毒从阴道腔获得CCR 5而不是CXCR 4。CD 1a + VDC中的局部复制促进病毒穿过粘膜上皮转移到更深处的CD 4 + T细胞。除了增加HIV-1在更深处的CD 4+淋巴细胞中感染和复制的能力外,我们假设CD 1a + VDCs还决定了哪些HIV-1变体在初始宿主中建立了生产性感染。在性传播期间,新感染的受试者仅从慢性感染的传播伴侣中传播的不同X4和R5病毒获得有限数量的R5变体。此外,与传播伙伴中存在的准种相比,感染R5病毒通常具有独特的基因型和表型。我们假设CD 1a + VDCs作为守门人发挥作用,既阻断X4病毒,又有利于R5变异体的复制,这些变异体具有感染后早期分离的HIV-1中常见的特性。在该提案中,我们将研究允许CD 1a + VDC对R5敏感但对X4 HIV-1耐药的机制。我们将检查这些细胞是否允许优先复制的感染株相比,非传播病毒。我们还将探索可以阻止CD 1a + VDC复制和病毒转移到CD 4 + T细胞的抑制剂。描述可以防止CD 1a + VDCs感染或病毒转移到CD 4 + T细胞的机制细节和因素,将提出旨在预防HIV-1粘膜传播的新型疫苗和杀微生物剂策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manish Sagar其他文献
Manish Sagar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manish Sagar', 18)}}的其他基金
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
抗体依赖性细胞毒性和 HIV-1 母婴传播
- 批准号:
10707299 - 财政年份:2022
- 资助金额:
$ 44.57万 - 项目类别:
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
抗体依赖性细胞毒性和 HIV-1 母婴传播
- 批准号:
10630722 - 财政年份:2022
- 资助金额:
$ 44.57万 - 项目类别:
Identification and characterization of individuals with elite anti-HIV-1 ADCC
精英抗 HIV-1 ADCC 个体的鉴定和特征描述
- 批准号:
9757695 - 财政年份:2018
- 资助金额:
$ 44.57万 - 项目类别:
The effects of opioid use on HIV-1 reservoir dynamics
阿片类药物的使用对 HIV-1 病毒库动态的影响
- 批准号:
10673865 - 财政年份:2018
- 资助金额:
$ 44.57万 - 项目类别:
The effects of opioid use on HIV-1 reservoir dynamics
阿片类药物使用对 HIV-1 病毒库动态的影响
- 批准号:
10620076 - 财政年份:2018
- 资助金额:
$ 44.57万 - 项目类别:
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract
CD1a 阴道树突状细胞和女性生殖道中 HIV-1 的获得
- 批准号:
9145066 - 财政年份:2015
- 资助金额:
$ 44.57万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 44.57万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 44.57万 - 项目类别: